Concepedia

Gerd Rühter

GR

Statistics

Publications

12

Citations

1.3K

H-Index

11

Active since

1983

Affiliations

Rapt Therapeutics (United States)(Current)

Lead Discovery Center (Germany)

Universität Hamburg

Max Planck Society

Max Planck Institute of Psychiatry

Gerd Rühter is an author at Rapt Therapeutics (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1983–2017

12

Publications

12

Palladium-Catalyzed Additions of Terminal Alkynes to Acceptor Alkynes

Barry M. Trost, Mark T. Sorum, Chuen Chan et al. · Journal of the American Chemical Society · 1997 · 342 citations

Natural Sciences, Chemistry, Catalysis +9

Metal-mediated approach to enynes

Barry M. Trost, Chuen Chan, Gerd Rühter · Journal of the American Chemical Society · 1987 · 255 citations

Natural Sciences, Chemistry, Materials Science +6

Selective inhibitors of the FK506-binding protein 51 by induced fit

S. Gaali, Alexander Kirschner, Serena Cuboni et al. · Nature Chemical Biology · 2014 · 244 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

Ulrich Lücking, Arne Scholz, Philip Lienau et al. · ChemMedChem · 2017 · 184 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties

Jakob Hartmann, Klaus V. Wagner, S. Gaali et al. · Journal of Neuroscience · 2015 · 114 citations · Full text

Medicine, Neuroscience, Pharmacology +13

1–5 of 12